anmelden
OMX Stockholm 30
3.115,98
PKT
+16,48
PKT
+0,53
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Stockholm 30-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 09.12.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 05.12.19 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 03.12.19 | AstraZeneca Sell | UBS AG | |
| 27.11.19 | AstraZeneca Reduce | HSBC | |
| 22.11.19 | AstraZeneca overweight | Barclays Capital | |
| 15.11.19 | ABB (Asea Brown Boveri) buy | HSBC | |
| 12.11.19 | AstraZeneca buy | Deutsche Bank AG | |
| 12.11.19 | Volvo (B) Underweight | Morgan Stanley | |
| 11.11.19 | AstraZeneca Sell | UBS AG | |
| 11.11.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 08.11.19 | Ericsson (Telefon L.M.Ericsson) (B) overweight | Morgan Stanley | |
| 08.11.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 07.11.19 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 07.11.19 | AstraZeneca buy | Deutsche Bank AG | |
| 06.11.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 06.11.19 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 31.10.19 | Ericsson (Telefon L.M.Ericsson) (B) Outperform | Credit Suisse Group | |
| 30.10.19 | AstraZeneca buy | Deutsche Bank AG | |
| 30.10.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 29.10.19 | Volvo (B) buy | Goldman Sachs Group Inc. | |
| 29.10.19 | AstraZeneca Sell | UBS AG | |
| 29.10.19 | AstraZeneca buy | Kepler Cheuvreux | |
| 29.10.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.10.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 29.10.19 | AstraZeneca Outperform | Credit Suisse Group | |
| 28.10.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 25.10.19 | AstraZeneca buy | Deutsche Bank AG | |
| 25.10.19 | AstraZeneca Outperform | Credit Suisse Group | |
| 24.10.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 24.10.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 24.10.19 | AstraZeneca Sell | UBS AG | |
| 24.10.19 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 24.10.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 23.10.19 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 23.10.19 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 23.10.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 22.10.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 22.10.19 | Volvo (B) buy | Goldman Sachs Group Inc. | |
| 22.10.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 21.10.19 | Volvo (B) Sector Perform | RBC Capital Markets |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.